Neuropathic Pain

• Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain(PubMed)
• Sativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain (PubMed)
• Cannabis, pain, and sleep: Lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine (PubMed)
• Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial (PubMed)
• Cannabinoids for neuropathic pain (PubMed)
• Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue (PubMed)
• Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial(PubMed)
• The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain (PubMed)
• Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation (PubMed)
• Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy(PubMed)
• Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: Mechanisms involved (PubMed)
• Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action (PubMed)
• Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors(PubMed)
• Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes (PubMed)
• Cannabinoids in the management of difficult to treat pain (PubMed)
• Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain (PubMed)
• Marijuana extract helps prevent chemo pain (UPI)
• Pot users less likely to take painkillers (American News Report)
• Amygdala activity contributes to the dissociative effect of cannabis on pain perception (International Association for the Study of Pain)
• Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review (British Journal of Clinical Pharmacology)
• Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy (British Journal of Pharmacology)
• Cannabinoid CB2 Receptors Regulate Central Sensitization and Pain Responses Associated with Osteoarthritis of the Knee Joint (PLOS)
• Cannabinoid–Opioid Interaction in Chronic Pain (Clinical pharmacology & Therapeutics)
• Cannabinoid receptors and pain  (WIREs Membr Transp Signal)
• Cannabinoids for Neuropathic Pain (Neuropathic Pain)
• Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials (British Journal of Clinical Pharmacology)
• Cannabinoids in the management of difficult to treat pain (Therapeutics and Clinical Risk Management)
• Cannabinoids suppress inflammatory and neuropathic pain by targeting 3 glycine receptors (The Journal of Experimental Medicine)
• Clinical Implications for Cannabinoid Use in the Rheumatic Diseases (Arthritis & Rheumatism)
• Role of Cannabinoids in Pain Management (GW Pharmaceuticals)
• Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes  (Bentham Science)
• Targeting CB2 receptors and the endocannabinoid system for the treatment of pain (HHS Public Access)
• The Endocannabinoid System, Cannabinoids, and Pain (Rambam Maimonides Medical Journal)
• Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use(National Institute on Drug Abuse)